The risk of lung cancer for young breast cancer survivors

August 7, 2018 by Jean-Philippe Pignol And Nienke Hoekstra, The Conversation
New research shows the risk of lung cancer slowly increases five to 10 years after a breast radiation treatment; a form of brachytherapy developed in Canada is the safest treatment to reduce this risk. Credit: Shutterstock

Women who have been lucky enough to survive breast cancer may face increased risk of lung cancers, according to a new study in Radiotherapy and Oncology. The study shows how this can be prevented—limiting the radiation dose to a lung, using a treatment which targets only a small part of the breast.

Breast cancer is the most frequently diagnosed cancer in women, with more than 266,000 new cases diagnosed in 2018 in the United States.

Thanks to the widespread use of screening mammography, most women are now diagnosed at an early stage —meaning that the cancer has only grown in the breast and not spread under the armpit or to distant organs. These individuals have a good prognosis with only a 1.3 per cent risk of dying of cancer recurrence after five years.

Treatment currently involves a limited breast surgery followed by multiple daily treatments targeting the whole breast. However, despite being cautiously delivered, a small amount of radiation can spill into the lung.

Using a complex predictive model called the Biologic Effects of Ionizing Radiation (BEIR) VII, and by testing multiple radiation techniques on a realistic model of a patient, the study by Ph.D. student Nienke Hoekstra shows that the risk of slowly increases five to 10 years after a breast radiation treatment. It reaches three per cent of surviving patients after more than 30 years.

A small part of the breast

This risk of lung cancer is a real concern for young patients diagnosed with early stage breast cancers —for example, a ductal carcinoma in situ (DCIS), which is a form of non-invasive cancer and hence a very highly curable disease. These patients have the chance of living long enough to experience this scary treatment side-effect.

The good news is that risk is not the same for all radiotherapy techniques. The study shows that a new form of radiotherapy for early-stage breast cancers —called accelerated partial breast irradiation (APBI) —dramatically reduces this risk.

APBI delivers the radiation treatment to only a small portion of the breast. It focuses on the cavity left after the surgery, where there is risk that cancer cells may remain.

Robotic delivery of radiation from all angles around the breast is the focus of ongoing research at Erasmus University. Author provided

There are multiple advantages to APBI, including the delivery of treatment in just five days. And the study found it results in much lower radiation exposure to body organs, including the lungs, than conventional treatments.

APBI is a technique on the rise. This study adds to the growing amount of evidence that it should be the preferred technique for women with very low-risk breast cancer.

But not all patients will benefit from APBI. Some need more complex and extensive radiotherapy to save their lives. Patients should be encouraged to discuss this with their radiation oncologist.

Tiny radioactive seeds

Among APBI techniques tested, "brachytherapy" —a form of radiotherapy where radioactive material is implanted inside the surgical cavity —appears to be the safest.

A particular form of brachytherapy developed in Canada, called "permanent breast seed implant," is the one with the lowest risk of secondary lung cancer.

This technique, which is also used to treat prostate cancer, involves the permanent implantation of tiny radioactive seeds, the size of a grain of rice, during a one-hour procedure performed under light sedation. Patients are discharged the same day.

The radiation emitted by the radioactive seeds is so weak that it is absorbed within a few millimetres and hence rarely reaches other organs.

The good news is that there is still lots of room for improvement —for example, using a robotic delivery of radiation from all angles around the breast to better avoid the lung. This is the focus of ongoing research.

Explore further: Cleveland Clinic leads development of new guidelines for radiation in breast cancer

Related Stories

Cleveland Clinic leads development of new guidelines for radiation in breast cancer

October 26, 2017
Cleveland Clinic researcher Chirag Shah, M.D., led the development of updated guidelines for the appropriate and safe utilization of accelerated partial-breast irradiation (APBI). The guidelines are published online in the ...

TGFB1 mutation ups radiation-induced breast fibrosis risk

August 2, 2018
(HealthDay)—The C-509T allele in the promoter region of transforming growth factor β (TGFB1) is associated with radiation-induced breast fibrosis risk among patients with early-stage breast cancer, according to study published ...

Targeted radiotherapy for breast cancer offers good quality of life and fewer side effects

April 22, 2018
Quality of life for women treated with a more targeted radiotherapy treatment - called accelerated partial breast irradiation - is at least as good as quality of life for women treated with standard radiotherapy, according ...

Radiotherapy risks are much higher for smokers

March 20, 2017
Smokers treated for breast cancer have much higher risks than non-smokers of developing lung cancer or heart attack as a result of radiotherapy - according to a new study funded by Cancer Research UK and published today in ...

Women with DCIS at lowest risk of recurrence if they are post-menopausal or ER+

March 21, 2018
Patients with an early form of breast cancer are less likely to suffer a recurrence if they are post-menopausal or if their tumour is oestrogen receptor positive, according to research presented at the 11th European Breast ...

Targeted radiation shows promise in early breast cancer

March 10, 2016
(HealthDay)—For women with early-stage breast cancer, targeted doses of radiation therapy may be as effective as standard radiation treatment of the entire breast, according to research presented at the European Breast ...

Recommended for you

Why some cancers affect only young women

October 19, 2018
Among several forms of pancreatic cancer, one of them specifically affects women, often young. How is this possible, even though the pancreas is an organ with little exposure to sex hormones? This pancreatic cancer, known ...

Scientists to improve cancer treatment effectiveness

October 19, 2018
Together with researchers from the University of Nantes and the University of Reims Champagne-Ardenne in France, experts from the National Research Nuclear University MEPhI have recently developed a quantum dot-based microarray ...

Mutant cells colonize our tissues over our lifetime

October 18, 2018
By the time we reach middle age, more than half of the oesophagus in healthy people has been taken over by cells carrying mutations in cancer genes, scientists have uncovered. By studying normal oesophagus tissue, scientists ...

Study involving hundreds of patient samples may reveal new treatment options of leukemia

October 17, 2018
After more than five years and 672 patient samples, an OHSU research team has published the largest cancer dataset of its kind for a form of leukemia. The study, "Functional Genomic Landscape of Acute Myeloid Leukemia", published ...

A 150-year-old drug might improve radiation therapy for cancer

October 17, 2018
A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more sensitive to radiation therapy, according to a recent study led by researchers at The Ohio State University Comprehensive Cancer ...

Loss of protein p53 helps cancer cells multiply in 'unfavourable' conditions

October 17, 2018
Researchers have discovered a novel consequence of loss of the tumour protein p53 that promotes cancer development, according to new findings in eLife.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.